Deoxyshikonin

Research use only, not for human use.

Deoxyshikonin may be a new drug candidate for wound healing and treatment of lymphatic diseases.

Deoxyshikonin may be a new drug candidate for wound healing and treatment of lymphatic diseases. Deoxyshikonin enhances the ability of human dermal lymphatic microvascular endothelial cells (HMVEC-dLy) to undergo time-dependent in vitro cord formation. Deoxyshikonin and dodecyl gallate show significantly synergic antimicrobial activity with penicillin in vivo and in vitro, and can effectively reduce nasopharyngeal and lung colonization caused by different penicillin-resistant pneumococcal serotypes.

Arnebin 7, Deoxyshikonin

Cell Cycle/DNA Damage

DNA/RNA Synthesis

Others

——

——

43043-74-9

272.3

C16H16O4

98%

——

CC(=CCCC1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)C

1,4-Naphthalenedione, 5,8-dihydroxy-2-(4-methyl-3-pentenyl)-

(-20℃)

With Ice Pack

≥ 2 years